News & Updates

HCV treatment easy on kidney in infected patients with CKD

06 Aug 2021

Both sofosbuvir and nonsofosbuvir-based regimens work to restore renal function in patients with chronic hepatitis C virus (HCV) infection and concomitant chronic kidney disease (CKD), particularly those with significant renal impairment, according to a study.

HCV treatment easy on kidney in infected patients with CKD

06 Aug 2021

Thiopurines do not exacerbate risk of post-ERC pancreatitis

05 Aug 2021

In patients with primary sclerosing cholangitis, past or present use of thiopurines does not increase the risk of post-endoscopic retrograde cholangiography (ERC) pancreatitis, a recent study has found.

Thiopurines do not exacerbate risk of post-ERC pancreatitis

05 Aug 2021

Multitarget FIT better than standard test for colorectal cancer screening

02 Aug 2021

A multitarget faecal immunochemical test (mtFIT) is more accurate than conventional FIT in detecting advanced neoplasia due to an increased detection of advanced adenomas, according to a study.

Multitarget FIT better than standard test for colorectal cancer screening

02 Aug 2021

TVB-2640 impresses in nonalcoholic steatohepatitis

01 Aug 2021

Use of the fatty acid synthase (FASN) inhibitor TVB-2640 in the treatment of patients with nonalcoholic steatohepatitis (NASH) yields dose-dependent improvements in liver fat as well as biochemical, inflammatory, and fibrotic biomarkers, according to the results of the phase IIa trial 3V2640-CLIN-005 (FASCINATE-1).

TVB-2640 impresses in nonalcoholic steatohepatitis

01 Aug 2021

IBD risk similar between IL-17 inhibitor and etanercept

29 Jul 2021

In patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis, use of an interleukin (IL)17-inhibitor does not contribute to an increase in the risk of inflammatory bowel disease (IBD) when compared with etanercept, according to a study.

IBD risk similar between IL-17 inhibitor and etanercept

29 Jul 2021

Prednisone, but not biologic use, tied to increased COVID-19 severity

28 Jul 2021 by

Use of prednisone prior to SARS-CoV-2 diagnosis may be linked to a higher risk of severe COVID-19 outcomes such as hospitalization, intensive care unit (ICU) admission, and death, according to a retrospective community-based study.

Prednisone, but not biologic use, tied to increased COVID-19 severity

28 Jul 2021

Sleep problems prevalent in functional gastrointestinal disorders

28 Jul 2021

Irritable bowel syndrome and functional dyspepsia, along with most of their major subtypes except constipation-predominant IBS, appear to go hand in hand with a range of sleep disturbances, as reported in a study.

Sleep problems prevalent in functional gastrointestinal disorders

28 Jul 2021

Nutrient drinking test a promising biomarker in functional dyspepsia

25 Jul 2021

A satiety drinking test (SDT) shows potential as a diagnostic biomarker in functional dyspepsia (FD), indicating gastric accommodation (GA), reports a recent study, noting that further studies are warranted to confirm its role as a predictor for treatment outcome in FD.

Nutrient drinking test a promising biomarker in functional dyspepsia

25 Jul 2021

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

24 Jul 2021

Treatment for chronic hepatitis B virus (CHB) infection results in significant reductions in risk of cirrhosis among noncirrhotic CHB patients, according to a study.

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

24 Jul 2021

Recombinant zoster vaccine cuts infection risk in older IBD patients

24 Jul 2021

Older inflammatory bowel disease (IBD) patients who receive the recombinant zoster vaccine are less likely to develop herpes zoster infection, as shown in a study.

Recombinant zoster vaccine cuts infection risk in older IBD patients

24 Jul 2021

News & Updates

Filter by Specialty:

Specialty:

HCV treatment easy on kidney in infected patients with CKD

HCV treatment easy on kidney in infected patients with CKD

Thiopurines do not exacerbate risk of post-ERC pancreatitis

Thiopurines do not exacerbate risk of post-ERC pancreatitis

Multitarget FIT better than standard test for colorectal cancer screening

Multitarget FIT better than standard test for colorectal cancer screening

TVB-2640 impresses in nonalcoholic steatohepatitis

TVB-2640 impresses in nonalcoholic steatohepatitis

IBD risk similar between IL-17 inhibitor and etanercept

IBD risk similar between IL-17 inhibitor and etanercept

Prednisone, but not biologic use, tied to increased COVID-19 severity

Prednisone, but not biologic use, tied to increased COVID-19 severity

Sleep problems prevalent in functional gastrointestinal disorders

Sleep problems prevalent in functional gastrointestinal disorders

Nutrient drinking test a promising biomarker in functional dyspepsia

Nutrient drinking test a promising biomarker in functional dyspepsia

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Recombinant zoster vaccine cuts infection risk in older IBD patients

Recombinant zoster vaccine cuts infection risk in older IBD patients